Literature DB >> 31912251

Challenges in the Diagnosis and Treatment of Lyme Disease.

Robert T Schoen1.   

Abstract

PURPOSE OF REVIEW: Since recognition in 1975, Lyme disease has become the most common vector-borne illness in North America and Europe. The clinical features are well-characterized and treatment is usually curative, but misperceptions about morbidity persist. The purpose of this review is to examine advances in the diagnosis and treatment of Lyme disease, as well as ongoing management challenges. RECENT
FINDINGS: It is useful to recognize that Lyme disease occurs in stages, with early- and late-stage disease. Clinical expression is in part determined by Borrelial variability. For example, some strains of Borrelia burgdorferi, the causative organism in North America, are particularly arthritogenic. Most patients with early Lyme disease can be cured with a single course of oral antibiotic therapy, in contrast to some patients with Lyme arthritis, a late-stage manifestation, who are more antibiotic refractory and require other treatment strategies. Successful treatment of Lyme disease begins with successful diagnosis and with an understanding of the emergence, clinical features, and impact of Lyme disease over the past half century.

Entities:  

Keywords:  Lyme arthritis; Lyme disease; Lyme disease treatment

Mesh:

Substances:

Year:  2020        PMID: 31912251     DOI: 10.1007/s11926-019-0857-2

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  98 in total

Review 1.  Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis.

Authors:  Allen C Steere; Sheryn M Angelis
Journal:  Arthritis Rheum       Date:  2006-10

2.  Course and Outcome of Early European Lyme Neuroborreliosis (Bannwarth Syndrome): Clinical and Laboratory Findings.

Authors:  Katarina Ogrinc; Lara Lusa; Stanka Lotrič-Furlan; Petra Bogovič; Daša Stupica; Tjaša Cerar; Eva Ružić-Sabljić; Franc Strle
Journal:  Clin Infect Dis       Date:  2016-05-08       Impact factor: 9.079

3.  Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans.

Authors:  Robert P Smith; Robert T Schoen; Daniel W Rahn; Vijay K Sikand; John Nowakowski; Dennis L Parenti; Mary S Holman; David H Persing; Allen C Steere
Journal:  Ann Intern Med       Date:  2002-03-19       Impact factor: 25.391

4.  Brief communication: hematogenous dissemination in early Lyme disease.

Authors:  Gary P Wormser; Donna McKenna; Jennafer Carlin; Robert B Nadelman; L Frank Cavaliere; Diane Holmgren; Daniel W Byrne; John Nowakowski
Journal:  Ann Intern Med       Date:  2005-05-03       Impact factor: 25.391

5.  A case revealing the natural history of untreated Lyme disease.

Authors:  Robert T Schoen
Journal:  Nat Rev Rheumatol       Date:  2010-12-21       Impact factor: 20.543

Review 6.  Efficacy and safety of pharmacological treatments for acute Lyme neuroborreliosis - a systematic review.

Authors:  R Dersch; M H Freitag; S Schmidt; H Sommer; S Rauer; J J Meerpohl
Journal:  Eur J Neurol       Date:  2015-06-08       Impact factor: 6.089

7.  Chronic neurologic manifestations of Lyme disease.

Authors:  E L Logigian; R F Kaplan; A C Steere
Journal:  N Engl J Med       Date:  1990-11-22       Impact factor: 91.245

Review 8.  Lyme disease: diagnostic issues and controversies.

Authors:  Maria E Aguero-Rosenfeld; Gary P Wormser
Journal:  Expert Rev Mol Diagn       Date:  2014-12-08       Impact factor: 5.225

9.  Testing practices and volume of non-Lyme tickborne diseases in the United States.

Authors:  Neeta P Connally; Alison F Hinckley; Katherine A Feldman; Melissa Kemperman; David Neitzel; Siok-Bi Wee; Jennifer L White; Paul S Mead; James I Meek
Journal:  Ticks Tick Borne Dis       Date:  2015-10-30       Impact factor: 3.744

Review 10.  Is the risk of early neurologic Lyme borreliosis reduced by preferentially treating patients with erythema migrans with doxycycline?

Authors:  Franc Strle; Daša Stupica; Petra Bogovič; Paul Visintainer; Gary P Wormser
Journal:  Diagn Microbiol Infect Dis       Date:  2018-02-02       Impact factor: 2.803

View more
  5 in total

1.  Global seroprevalence and sociodemographic characteristics of Borrelia burgdorferi sensu lato in human populations: a systematic review and meta-analysis.

Authors:  Yan Dong; Guozhong Zhou; Wenjing Cao; Xin Xu; Yu Zhang; Zhenhua Ji; Jiaru Yang; Jingjing Chen; Meixiao Liu; Yuxin Fan; Jing Kong; Shiyuan Wen; Bingxue Li; Peng Yue; Aihua Liu; Fukai Bao
Journal:  BMJ Glob Health       Date:  2022-06

2.  Lyme Disease in Humans.

Authors:  Justin D Radolf; Klemen Strle; Jacob E Lemieux; Franc Strle
Journal:  Curr Issues Mol Biol       Date:  2020-12-11       Impact factor: 2.081

3.  Predicting Lyme Disease From Patients' Peripheral Blood Mononuclear Cells Profiled With RNA-Sequencing.

Authors:  Daniel J B Clarke; Alison W Rebman; Allison Bailey; Megan L Wojciechowicz; Sherry L Jenkins; John E Evangelista; Matteo Danieletto; Jinshui Fan; Mark W Eshoo; Michael R Mosel; William Robinson; Nitya Ramadoss; Jason Bobe; Mark J Soloski; John N Aucott; Avi Ma'ayan
Journal:  Front Immunol       Date:  2021-03-08       Impact factor: 7.561

4.  Forty Years of Evidence on the Efficacy and Safety of Oral and Injectable Antibiotics for Treating Lyme Disease of Adults and Children: A Network Meta-Analysis.

Authors:  Jiaru Yang; Shiyuan Wen; Jing Kong; Peng Yue; Wenjing Cao; Xin Xu; Yu Zhang; Jingjing Chen; Meixiao Liu; Yuxin Fan; Lisha Luo; Taigui Chen; Lianbao Li; Bingxue Li; Yan Dong; Suyi Luo; Guozhong Zhou; Aihua Liu; Fukai Bao
Journal:  Microbiol Spectr       Date:  2021-11-10

5.  Immunoinformatics-Based Proteome Mining to Develop a Next-Generation Vaccine Design against Borrelia burgdorferi: The Cause of Lyme Borreliosis.

Authors:  Kashaf Khalid; Omar Ahsan; Tanwir Khaliq; Khalid Muhammad; Yasir Waheed
Journal:  Vaccines (Basel)       Date:  2022-08-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.